Company
OmicLab Limited, a high-tech enterprise, is dedicated to the development and application of bioinformatics and machine learning technologies in the field of precision medicine.
Core Business and Technology: OmicLab Limited is committed to building a digital analysis and testing platform. By leveraging advanced bioinformatics techniques and machine learning methods, the company propels research and the transformation of academic research into practical applications within the life sciences and healthcare sectors. The company's CombCure Precision Cancer Diagnosis and Treatment Platform offers digital solutions to hospitals and clinical testing institutions, assisting patients in receiving faster and safer precision medical services.
Awards and Support: OmicLab Limited has received support from the City University of Hong Kong's HK Tech 300 Angel Fund and Seed Fund. It has also been recognized in several significant competitions, including winning the Silver Award in the "Challenge Cup" Chinese College Students' Entrepreneurship Competition and the Silver Award in the 6th China International ""Internet Plus"" College Students' Innovation and Entrepreneurship Competition.
